Proteome Sciences said this week it had appointed Chee Gee See director of personalized medicine.
Previously Gee See was a biomarker and experimental medicine leader at Roche. Before that he was an analyst at GlaxoSmithKline.
Singulex said this week that it has appointed Jeffrey Bishop vice president, research and development and Linda Greub vice president, business development.
Bishop was previously vice president, research and development at Alere.
Greub was previously global director of strategy, business development at Novartis. Prior to that she was senior director, strategy and business development at Applied Biosystems as well as a senior healthcare analyst for several investment banks and hedge funds.